Search - tctmd.com

Displaying 1 - 20 of 27

Sort: Relevancy | Date

News Conference News AHA 2025

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

Caitlin E. Cox

November 08, 2025

News Daily News

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Yael L. Maxwell

October 24, 2025

News Daily News

Risk Factors Present in Nearly All Patients Who Develop CVD

Michael O'Riordan

October 02, 2025

News Opinion CV Team Dispatch

September 2025 Dispatch for the CV Team

L.A. McKeown

September 30, 2025

News Daily News

AI-Supported Coaching Shows Promise for Improving Glycemic Control

L.A. McKeown

August 25, 2025

News Daily News

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Michael O'Riordan

August 01, 2025

News Daily News

Top General Cardiology and Prevention News of 2024

Caitlin E. Cox

December 30, 2024

News Opinion CV Team Dispatch

December 2024 Dispatch for the CV Team

L.A. McKeown

December 20, 2024

News Daily News

Another Low-Cal Sugar Substitute Linked to Cardiovascular Risks

L.A. McKeown

June 12, 2024

News Daily News

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

L.A. McKeown

June 05, 2024

News Daily News

Counting Quality, Not Carbs, May Be Key to Weight Management

L.A. McKeown

January 05, 2024

News Daily News

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

Michael O'Riordan

January 05, 2024

News Daily News

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Michael O'Riordan

December 08, 2023

News Daily News

Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds

Todd Neale

December 06, 2023

News Daily News

FDA Grants Tirzepatide a New Indication for Obesity Management

L.A. McKeown

November 08, 2023

News Daily News

Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

Michael O'Riordan

March 01, 2023

News Daily News

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Michael O'Riordan

December 14, 2022

News Conference News AHA 2022

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Michael O'Riordan

November 05, 2022

News Daily News

Acute MI, Stroke Risks Rise in the Months After Gout Flares

Todd Neale

August 02, 2022

News Daily News

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

L.A. McKeown

June 09, 2022

Advertisement

Triple Agonist Appears Promising for Patients With Severe Hypertriglyceridemia

Semaglutide’s CV Effects Only Partially Tied to Weight Loss: SELECT Analysis

Risk Factors Present in Nearly All Patients Who Develop CVD

September 2025 Dispatch for the CV Team

AI-Supported Coaching Shows Promise for Improving Glycemic Control

Glipizide, Commonly Used Sulfonylurea, Linked to Greater CV Risks

Top General Cardiology and Prevention News of 2024

December 2024 Dispatch for the CV Team

Another Low-Cal Sugar Substitute Linked to Cardiovascular Risks

As Trends Reverse in CVD, AHA Warns of Soaring Costs and Illness

Counting Quality, Not Carbs, May Be Key to Weight Management

No Signs of Hypoglycemia Causing CVD in CAROLINA and CARMELINA

Bempedoic Acid Reassures in Patients With and Without Diabetes: CLEAR Outcomes

Long-term ALLHAT Data Affirm Parity of Antihypertensive Meds

FDA Grants Tirzepatide a New Indication for Obesity Management

Don’t Just Prescribe a Statin—Measure and Control LDL, Say NLA, ASPC

CVD Claimed 20 Million Lives in 2021, but Disease Burden Varies Globally

Pemafibrate Fails to Lower CVD Risk in Patients With High Triglycerides: PROMINENT

Acute MI, Stroke Risks Rise in the Months After Gout Flares

SURMOUNT-1: Tirzepatide Drastically Reduces Weight in Obese Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content